Abstract
Patients of Tuberculosis have poor treatment outcome with high mortality. Immunodeficiency appears to be an important risk factor in the development of multi drug resistance (MDR) and extensively drug resistance (XDR) tuberculosis. Mesenchymal stromal cell (MSCs) having immunomodulatory effect, have been used as adjunct autologous treatment. Thereby, it helps in transforming chronic inflammation into productive immune response. Stem cells therapy is based on the principle, that it migrates to the site of injury and forms tissue specific cell type that can replace the damaged tissue. Autologous MSCs have been used as an adjunct treatment in MDR TB in the lungs for accelerating clearance of pathogenic bacteria and early recovery. It appears to be a promising procedure for enhancing the efficacy of anti-TB therapy in MDR and XDR subjects.
Keywords: Multi-drug resistance, extremely drug resistance, tuberculosis, mesenchymal stem cell therapy.
Current Respiratory Medicine Reviews
Title:Stem Cells in MDR-TB and XDR - TB
Volume: 10 Issue: 4
Author(s): Vijay K. Arora, Paramjit S. Dhot and P. Singhal
Affiliation:
Keywords: Multi-drug resistance, extremely drug resistance, tuberculosis, mesenchymal stem cell therapy.
Abstract: Patients of Tuberculosis have poor treatment outcome with high mortality. Immunodeficiency appears to be an important risk factor in the development of multi drug resistance (MDR) and extensively drug resistance (XDR) tuberculosis. Mesenchymal stromal cell (MSCs) having immunomodulatory effect, have been used as adjunct autologous treatment. Thereby, it helps in transforming chronic inflammation into productive immune response. Stem cells therapy is based on the principle, that it migrates to the site of injury and forms tissue specific cell type that can replace the damaged tissue. Autologous MSCs have been used as an adjunct treatment in MDR TB in the lungs for accelerating clearance of pathogenic bacteria and early recovery. It appears to be a promising procedure for enhancing the efficacy of anti-TB therapy in MDR and XDR subjects.
Export Options
About this article
Cite this article as:
K. Arora Vijay, S. Dhot Paramjit and Singhal P., Stem Cells in MDR-TB and XDR - TB, Current Respiratory Medicine Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/1573398X11666150109223613
DOI https://dx.doi.org/10.2174/1573398X11666150109223613 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Selections
Recent Patents on Nanotechnology Immunology of O-Glycosylated Proteins: Approaches to the Design of a MUC1 Glycopeptide-Based Tumor Vaccine
Current Protein & Peptide Science NAD(P) Biosynthesis Enzymes as Potential Targets for Selective Drug Design
Current Medicinal Chemistry Patents in the Era of Genomics: An Overview
Recent Patents on DNA & Gene Sequences Diabetes Mellitus or Tuberculosis: Which is the Greater Evil?
Current Respiratory Medicine Reviews Anticonvulsant and Antitubercular Activities of 6-Phenyl/Biphenyl-4-yl-2- [2-(pyridin-2-ylamino)-ethyl]- and 6-(Biphenyl-4yl)-2-(2N-subtituted amin- 1-yl)-ethyl derivatives of 4,5-dihydropyridazin-3(2H)-one
Letters in Drug Design & Discovery The Epidemiological and Pangenome Landscape of <i>Staphylococcus aureus</i> and Identification of Conserved Novel Candidate Vaccine Antigens
Current Proteomics Chemoinfectomics in Drug Design and Development
Anti-Infective Agents Chronic Granulomatous Disease in Childhood
Current Pediatric Reviews Editorial (Thematic Issue: Tropical Rheumatology)
Current Rheumatology Reviews State of the Art Review and Report of New Tool for Drug Discovery
Current Topics in Medicinal Chemistry Nitric Oxide: Friendly Rivalry in Tuberculosis
Current Signal Transduction Therapy Honey as a Source of Dietary Antioxidants: Structures, Bioavailability and Evidence of Protective Effects Against Human Chronic Diseases
Current Medicinal Chemistry Inhibition of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase (Dxr): A Review of the Synthesis and Biological Evaluation of Recent Inhibitors
Current Topics in Medicinal Chemistry Medicinal Chemistry of Inhibitors Targeting Resistant Bacteria
Current Topics in Medicinal Chemistry Keto and Exomethylene Pyranonucleosides as Antitumor Agents
Mini-Reviews in Medicinal Chemistry The Chemical Composition and Anti-mycobacterial Activities of <i>Trachyspermum copticum</i> and <i>Pelargonium graveolens</i> Essential Oils
Recent Patents on Anti-Infective Drug Discovery Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target
Current Medicinal Chemistry QSAR Based Design of New Antitubercular Compounds: Improved Isoniazid Derivatives Against Multidrug-Resistant TB
Current Pharmaceutical Design Red Blood Cells as Modulators of T Cell Growth and Survival
Current Pharmaceutical Design